JD.com, Inc. (JD) earnings per share

JD.com, Inc. reports in CNY; the per-share figures below are in CNY as filed with SEC EDGAR, not US dollars.
Annual history
Fiscal years 2014 – 2025
CNY / SHARE 14 PERIODS
Period End Diluted Filed
FY 2025 2025-12-31 ¥6.45 2026-04-16
FY 2024 2024-12-31 ¥13.43 2025-04-17
FY 2023 2023-12-31 ¥7.61 2024-04-18
FY 2022 2022-12-31 ¥3.21 2023-04-20
FY 2021 2021-12-31 -¥1.15 2022-04-28
FY 2020 2020-12-31 ¥15.84 2021-04-16
FY 2019 2019-12-31 ¥4.11 2020-04-15
FY 2018 2018-12-31 -¥0.87 2019-04-15
FY 2017 2017-12-31 -¥0.05 2018-04-27
FY 2016 2016-12-31 -¥1.36 2017-05-01
FY 2015 2015-12-31 -¥3.33 2016-04-18
FY 2014 2014-12-31 -¥5.35 2015-04-17
FY 2014 2013-12-31 -¥1.47 2015-04-17
FY 2014 2012-12-31 -¥2.18 2015-04-17
Quarterly history
Fiscal years 2018 – 2019
CNY / SHARE 4 PERIODS
Period End Diluted Filed
Q4 2019 2019-12-31 ¥1.22 2020-04-15
Q3 2019 2019-09-30 ¥2.89 2019-12-03
Q4 2018 2018-12-31 -¥1.66 2019-04-15
Q3 2019 2018-09-30 ¥0.79 2019-12-03
Free cash flow per share — Annual
Fiscal years 2014 – 2025 · (Operating CF − CapEx) ÷ Diluted Shares
CNY / SHARE 14 PERIODS
Period End FCF / Share Filed
FY 2025 2025-12-31 ¥3.75 2026-04-16
FY 2024 2024-12-31 ¥17.15 2025-04-17
FY 2023 2023-12-31 ¥17.50 2024-04-18
FY 2022 2022-12-31 ¥16.45 2023-04-20
FY 2021 2021-12-31 ¥11.82 2022-04-28
FY 2020 2020-12-31 ¥12.60 2021-04-16
FY 2019 2019-12-31 ¥7.48 2020-04-15
FY 2018 2018-12-31 ¥4.70 2019-04-15
FY 2017 2017-12-31 ¥8.10 2018-04-27
FY 2016 2016-12-31 ¥2.45 2017-05-01
FY 2015 2015-12-31 ¥0.06 2016-04-18
FY 2014 2014-12-31 ¥0.10 2015-04-17
FY 2014 2013-12-31 ¥1.67 2015-04-17
FY 2014 2012-12-31 ¥0.83 2015-04-17
Free cash flow per share — Quarterly
Fiscal years 2018 – 2019 · (Operating CF − CapEx) ÷ Diluted Shares
CNY / SHARE 4 PERIODS
Period End FCF / Share Filed
Q4 2019 2019-12-31 -¥0.50 2020-04-15
Q3 2019 2019-09-30 ¥7.07 2019-12-03
Q4 2018 2018-12-31 ¥1.45 2019-04-15
Q3 2019 2018-09-30 ¥3.18 2019-12-03

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. FCF / Share is computed as (Operating Cash Flow − Capital Expenditures) ÷ Diluted Shares Outstanding. When SEC companyfacts omits the direct diluted-share concept for an older period, we imply it from NetIncomeLoss ÷ EarningsPerShareDiluted. For financial filers whose operating cash flow includes customer-fund activity (e.g. Mercado Pago deposits), FCF may materially exceed net income because the fintech float is recorded inside OCF under US GAAP.

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

FCF source tags per fiscal year (14 periods)

The exact namespace:concept that fed Operating Cash Flow, CapEx, and the diluted-share denominator for each annual FCF / Share value. Filers swap between fallback concepts over the years (e.g. PaymentsToAcquireProductiveAssetsPaymentsToAcquirePropertyPlantAndEquipment), and older periods where SEC companyfacts omits the direct shares tag fall back to an implied share count from Net Income ÷ EPS Diluted.

Period Operating CF CapEx Diluted Shares
FY 2014 us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2014 us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2014 us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2015 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2016 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2017 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2018 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsForCapitalImprovements us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2019 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquirePropertyPlantAndEquipment us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2020 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquirePropertyPlantAndEquipment us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2021 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquirePropertyPlantAndEquipment us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2022 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquirePropertyPlantAndEquipment us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2023 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquirePropertyPlantAndEquipment us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2024 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquireProductiveAssets us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
FY 2025 us-gaap:NetCashProvidedByUsedInOperatingActivities us-gaap:PaymentsToAcquireProductiveAssets us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

JD CIK 0001549802 Source: EDGAR filings · all facts

Related tickers

FBRX

Forte Biosciences, Inc.

OFS

OFS CAPITAL CORPORATION

YJ

Yunji Inc.